Page last updated: 2024-10-23

benoxathian and Substance Withdrawal Syndrome

benoxathian has been researched along with Substance Withdrawal Syndrome in 1 studies

benoxathian: RN given refers to parent cpd; structure given in first source

Substance Withdrawal Syndrome: Physiological and psychological symptoms associated with withdrawal from the use of a drug after prolonged administration or habituation. The concept includes withdrawal from smoking or drinking, as well as withdrawal from an administered drug.

Research Excerpts

ExcerptRelevanceReference
"Morphine withdrawal was induced by intravenous (i."1.30Interruption of central noradrenergic pathways and morphine withdrawal excitation of oxytocin neurones in the rat. ( Brown, CH; Bull, PM; Leng, G; Ludwig, M; Munro, G; Murphy, NP; Russell, JA, 1998)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brown, CH1
Murphy, NP1
Munro, G1
Ludwig, M1
Bull, PM1
Leng, G1
Russell, JA1

Other Studies

1 other study available for benoxathian and Substance Withdrawal Syndrome

ArticleYear
Interruption of central noradrenergic pathways and morphine withdrawal excitation of oxytocin neurones in the rat.
    The Journal of physiology, 1998, Mar-15, Volume: 507 ( Pt 3)

    Topics: Adrenergic alpha-Antagonists; Analysis of Variance; Animals; Cerebral Ventricles; Cholecystokinin; E

1998